67728 Federal Register / Vol. 83, No. 249 / Monday, December 31, 2018 / Notices 

TABLE 6—CURRENT AND NEW NATIONAL AVERAGE OF ADDITIONAL FEES FOR ACCREDITED LABORATORIES UPDATE

[Additional fee updates at 20 percent increase] 

Laboratory classification 

(schedules) 

Current 

average 

(c) 

New 

average 

(n) 

LVA .......................................................................................................................................................................... $15 $18 

A ............................................................................................................................................................................... 50 60 

B ............................................................................................................................................................................... 60 80 

C .............................................................................................................................................................................. 83 99 

D .............................................................................................................................................................................. 97 117 

E ............................................................................................................................................................................... 112 134 

F ............................................................................................................................................................................... 126 152 

G .............................................................................................................................................................................. 141 169 

H .............................................................................................................................................................................. 155 186 

I ................................................................................................................................................................................ 170 204 

J ............................................................................................................................................................................... 184 220 

Table 6 shows the national average of 

Additional Fees for each schedule of 

accredited laboratory. Specifically, 

Table 6 represents the national average 

fees for each schedule for the current 

Additional Fees (noted with a ‘‘c’’) as 

paid biennially by laboratories that hold 

a CoA and the national average for the 

new Additional Fees (noted with a ‘‘n’’) 

that will be paid biennially by 

laboratories that hold a CoA. As 

discussed in section II. of this notice 

with comment period, Table 6 reflects a 

total increase of 20 percent across all 

schedules. 

TABLE 7—CLIA BIENNIAL CERTIFICATE FEES

Type of CLIA certificate Laboratory schedule Current fee New fee 

Certificate of Waiver (CoW) ......................................... Not applicable ............................................................... $150.00 $180.00 

PPM .............................................................................. Not applicable ............................................................... 200.00 240.00 

CoC and CoA ............................................................... LVA ............................................................................... 150.00 180.00 

CoC and CoA ............................................................... A ................................................................................... 150.00 180.00 

CoC and CoA ............................................................... B ................................................................................... 150.00 180.00 

CoC and CoA ............................................................... C ................................................................................... 430.00 516.00 

CoC and CoA ............................................................... D ................................................................................... 440.00 528.00 

CoC and CoA ............................................................... E ................................................................................... 650.00 780.00 

CoC and CoA ............................................................... F .................................................................................... 1,100.00 1,320.00 

CoC and CoA ............................................................... G ................................................................................... 1,550.00 1,860.00 

CoC and CoA ............................................................... H ................................................................................... 2,040.00 2,448.00 

CoC and CoA ............................................................... I ..................................................................................... 6,220.00 7,464.00 

CoC and CoA ............................................................... J .................................................................................... 7,940.00 9,528.00 

Table 7 depicts the current and new 

Certificate Fees, which reflects the 20 

percent increase across all schedules, 

with the exception of fees for the 

issuance of a CoR. 

D. Regulatory Reform Analysis Under 

E.O. 13771 

Executive Order 13771, titled 

Reducing Regulation and Controlling 

Regulatory Costs, was issued on January 

30, 2017 and requires that the costs 

associated with significant new 

regulations ‘‘shall, to the extent 

permitted by law, be offset by the 

elimination of existing costs associated 

with at least two prior regulations.’’ It 

has been determined that this notice 

with comment period is not a 

‘‘significant regulatory action’’ under 

E.O. 12866 and thus is not considered 

regulatory action under Executive Order 

13771. 

E. Conclusion 

Although the effect of the changes 

will increase laboratory costs, 

implementation of these changes will be 

negligible in terms of workload for 

laboratories as these fee increases are 

operational and technical in nature and 

do not require additional time to be 

spent by laboratory employees. 

We have determined that this notice 

with comment period would not have a 

significant economic impact on a 

substantial number of small entities or 

a significant impact in the operations of 

a substantial number of small rural 

hospitals and for these reasons, we are 

not preparing analyses for either the 

RFA or section 1102(b) of the Act. 

In accordance with the provisions of 

Executive Order 12866, this notice with 

comment period was reviewed by the 

Office of Management and Budget. 

Dated: December 14, 2018. 

Seema Verma, 

Administrator, Centers for Medicare & 

Medicaid Services. 

Dated: December 18, 2018. 

Alex M. Azar II, 

Secretary, Department of Health and Human 

Services. 

[FR Doc. 2018–28359 Filed 12–28–18; 11:15 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Physician-Focused Payment Model 

Technical Advisory Committee; 

Meetings 

ACTION: Notice of meetings. 

SUMMARY: This notice announces the 

2019 meetings of the Physician-Focused 

Payment Model Technical Advisory 

Committee (PTAC). These meetings will 

include deliberation and voting on 


khammond on DSK30JT082PROD with NOTICES
Federal Register / Vol. 83, No. 249 / Monday, December 31, 2018 / Notices 67729 

proposals for physician-focused 

payment models (PFPMs) submitted by 

individuals and stakeholder entities. All 

meetings are open to the public. 

DATES: The 2019 PTAC meetings will 

occur on the following dates: 

• Monday–Tuesday, March 11–12, 

2019, from 9:00 a.m. to 5:00 p.m. ET 

• Monday–Tuesday, June 17–18, 2019, 

from 9:00 a.m. to 5:00 p.m. ET 

• Monday–Tuesday, September 16–17, 

2019, from 9:00 a.m. to 5:00 p.m. ET 

• Monday–Tuesday, December 9–10, 

2019, from 9:00 a.m. to 5:00 p.m. ET 

Please note that times are subject to 

change. If the times change, registrants 

will be notified directly via email. 

ADDRESSES: All PTAC meetings will be 

held in the Great Hall of the Hubert H. 

Humphrey Building, 200 Independence 

Avenue SW, Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT:

Sarah Selenich, Designated Federal 

Officer, (202) 690–6870. 

SUPPLEMENTARY INFORMATION: 

Agenda and Comments. PTAC will 

hear presentations on proposed PFPMs 

that have been submitted by individuals 

and stakeholder entities. Following each 

presentation, PTAC will deliberate on 

the proposed PFPM. If PTAC completes 

its deliberation, PTAC will vote on the 

extent to which the proposed PFPM 

meets criteria established by the 

Secretary of Health and Human Services 

and on an overall recommendation to 

the Secretary. Time will be allocated for 

public comments. The agenda and other 

documents will be posted on the PTAC 

section of the ASPE website, https://

aspe.hhs.gov/ptac-physician-focusedpayment-model-technical-advisorycommittee, prior to the meeting. The 

agenda is subject to change. If the 

agenda does change, registrants will be 

notified directly via email, the website 

will be updated, and notification will be 

sent out through the PTAC email 

listserv (go to https://list.nih.gov/cgibin/wa.exe?A0=PTAC to subscribe). 

Meeting Attendance. These meetings 

are open to the public. The public may 

attend in person, via conference call, or 

view the meeting via livestream at 

www.hhs.gov/live. The conference call 

dial-in information will be sent to 

registrants prior to the meeting. Space 

may be limited, and registration is 

preferred. Registration may be 

completed online athttp://

www.cvent.com/d/gbq2tg. Name, 

organization name, and email address 

are submitted when registering. 

Registrants will receive a confirmation 

email shortly after completing the 

registration process. 

Special Accommodations. If sign 

language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact 

Angela Tejeda, no later than two weeks 

prior to the scheduled meeting. Please 

submit your requests by email to 

Angela.Tejeda@hhs.gov or by calling 

202–205–8327. 

Authority. 42 U.S.C. 1395(ee); Section 

101(e)(1) of the Medicare Access and 

CHIP Reauthorization Act of 2015; 

Section 51003(b) of the Bipartisan 

Budget Act of 2018. PTAC is governed 

by provisions of the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

App.), which sets forth standards for the 

formation and use of federal advisory 

committees. 

Dated: December 19, 2018. 

Brenda Destro, 

Deputy Assistant Secretary for Planning and 

Evaluation (HSP). 

[FR Doc. 2018–28402 Filed 12–28–18; 8:45 am] 

BILLING CODE 4150–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Request for Public Comments on the 

Pain Management Best Practices InterAgency Task Force Draft Report on 

Pain Management Best Practices: 

Updates, Gaps, Inconsistencies, and 

Recommendations 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, U.S. Department of Health 

and Human Services (HHS). 

ACTION: Notice of request for public 

comments on the Draft Report on Pain 

Management Best Practices: Updates, 

Gaps, Inconsistencies, and 

Recommendations, which proposes 

updates to best practices and 

recommendations for pain management, 

including chronic and acute pain. 

SUMMARY: The Comprehensive 

Addiction and Recovery Act of 2016 

(CARA), requires that the public be 

given at least ninety (90) days to submit 

comments on any proposed updates and 

recommendations developed by the 

Pain Management Best Practices InterAgency Task Force (Task Force). The 

Task Force is requesting comments on 

the Draft Report on Pain Management 

Best Practices: Updates, Gaps, 

Inconsistencies, and Recommendations 

(hereinafter referred to as Draft Report). 

Section 101 of the CARA authorized the 

creation of the Task Force to identify 

gaps or inconsistencies, and propose 

updates to best practices and 

recommendations for pain management, 

including chronic and acute pain. The 

Secretary of HHS convened the Task 

Force in cooperation with the Secretary 

of Veterans Affairs and Secretary of 

Defense. On September 26, 2018, the 

Task Force voted on the proposed 

updates and recommendations that 

would be provided to the public for 

comment, which are included in the 

Draft Report. Once the ninety (90) day 

comment period concludes, the Task 

Force will consider comments received 

and compile a Final Report with its 

proposed updates and 

recommendations. 

DATES: Comments for consideration by 

the Task Force should be received no 

later than 5:00 p.m. Eastern Time (ET) 

on April 1, 2019. 

ADDRESSES: The Draft Report is 

available at https://www.hhs.gov/ash/ 

advisory-committees/pain/index.html. 

Written comments may be submitted by 

any of the following three methods: (1) 

Submit through the Federal 

eRulemaking Portal at http://

www.regulations.gov, Docket Number: 

HHS–OS–2018–0027, (2) Email to: 

paintaskforce@hhs.gov, or (3) Mail 

written comments to the U.S. 

Department of Health and Human 

Services, Office of the Assistant 

Secretary for Health, 200 Independence 

Avenue SW, Room 736E, Attn: Alicia 

Richmond Scott, Pain Management Best 

Practices Inter-Agency Task Force 

Designated Federal Officer, Washington, 

DC 20201. For more detailed 

instructions on submitting comments, 

see the ‘‘Instructions for Commenters’’ 

section of REQUEST FOR COMMENTS. 

FOR FURTHER INFORMATION CONTACT: 

Alicia Richmond Scott, Designated 

Federal Officer, Pain Management Best 

Practices Inter-Agency Task Force, U.S. 

Department of Health and Human 

Services, Office of the Assistant 

Secretary for Health, 200 Independence 

Avenue SW, Room 736E, Washington, 

DC 20201. Phone: 240–453–2816. Email: 

paintaskforce@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Comprehensive Addiction and Recovery 

Act of 2016 (CARA), Public Law 114– 

198, required the Secretary of Health 

and Human Services, in cooperation 

with the Secretaries of Defense and 

Veterans Affairs, to convene the Task 

Force no later than two years after the 

CARA enactment. The Task Force is 

required to propose updates on best 

practices and recommendations to 

address gaps or inconsistencies for pain 

management, including chronic and 

acute pain, and submit such updates 

and recommendations to relevant 

Federal agencies and the general public. 

The duties of the Task Force are to: 

• Identify, review, determine, and 

propose updates to gaps or 

inconsistencies between best practices 


khammond on DSK30JT082PROD with NOTICES